News
Oncology treatment errors: Emerging data shed light on risk factors, prevention
- Author:
- Susan London
ORLANDO – Three studies focus on risk factors for errors that occur during the delivery of cancer treatment, and how to prevent those errors.
News
Ibrutinib monotherapy data in previously treated MZL is available
- Author:
- Susan London
How might the first FDA-approved drug for MZL affect ongoing studies and treatment for the disease?
News
Pembrolizumab advances in relapsed/refractory classic Hodgkin lymphoma
- Author:
- Susan London
The overall response rate was 69% with immune checkpoint inhibitor.
News
Waldenström macroglobulinemia panel advises on IgM paraproteinemic neuropathies
- Author:
- Susan London
The indications for invasive testing and definitive answers about when and how to treat peripheral neuropathies due to Waldenström...
News
Survivorship care models work, some better than others
- Author:
- Susan London
ORLANDO – Survivorship care models can reduce health care use and costs without compromising outcomes, but quality of care differs across models...
News
Breast cancer info on centers’ sites leaves room for improvement
- Author:
- Susan London
ORLANDO – The websites of leading cancer centers often fail to provide critical information about breast cancer treatment.
News
Real-world EGFR and ALK testing of NSCLC falls short
- Author:
- Susan London
ORLANDO – Tumor-associated mutations go unnoticed surprisingly often.
News
Portfolio of physician-led measures nets better quality of care
- Author:
- Susan London
ORLANDO – Reducing variation in patients’ experiences can improve overall quality of care.
News
Decision support tool appears to safely reduce CSF use
- Author:
- Susan London
ORLANDO – How can a new decision support tool reduce CFS use for patients receiving chemotherapy for lung cancer?
News
Lung cancer pathways reduce cost of care without compromising outcomes
- Author:
- Susan London
ORLANDO – Implementation of lung cancer clinical pathways yielded substantial cost savings with no worsening of survival.
News
Ublituximab was safe, highly active in rituximab-pretreated B-cell NHL, CLL
- Author:
- Susan London
Ublituximab had good safety and antitumor activity in rituximab-relapsed or -refractory B-cell non-Hodgkin lymphoma or chronic lymphocytic...
News
High continuation rates for IUDs, implants at 2 years
- Author:
- Susan London
Are women satisfied with their IUDs or contraceptive implants? A new real-world study suggests that they are.
News
Heart disease risk soars in young adults with coronary calcium
- Author:
- Susan London
Young adults with even small amounts of coronary calcium have a 5-fold higher risk of coronary heart disease and a 1.6-fold risk of death,...
Article
Resources and technologies are making teen drivers safer
- Author:
- Susan London
Dr. Joseph O’Neil discusses how you can help parents keep teen drivers safe behind the wheel.
Article
Ischemia-repairing cells fall short for treating intermittent claudication
- Author:
- Susan London
Therapy with cells known to repair ischemic damage does not improve intermittent claudication of the legs in unselected patients, according to...